ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 228 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $54,386,000 | -2.5% | 1,443,738 | -27.8% | 0.72% | +15.3% |
| Q2 2017 | $55,780,000 | -18.9% | 2,000,000 | 0.0% | 0.63% | -25.7% |
| Q1 2017 | $68,760,000 | +44.5% | 2,000,000 | +21.2% | 0.84% | +17.0% |
| Q4 2016 | $47,586,000 | +87.0% | 1,650,000 | +106.2% | 0.72% | +115.5% |
| Q3 2016 | $25,448,000 | -2.0% | 800,000 | 0.0% | 0.34% | -19.5% |
| Q2 2016 | $25,968,000 | – | 800,000 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |